Perioperative cognitive behavioural therapy compared with pain education and mindfulness for chronic postsurgical pain in breast cancer patients with high pain catastrophising characteristics: a randomised, controlled, parallel group clinical trial

BJA OpenPublished Randomised controlled trial

Authors' conclusion

Delivery of four one-to-one, perioperative CBT or PEM sessions to patients with high pain catastrophising characteristics achieved similar reductions in pain intensity at 3 months after breast cancer surgery.

Study context

Population
Women having primary breast cancer surgery with high pain catastrophising (pain catastrophising scale (PCS) ≥24)208 screened
Participants
45 women
Comparison
Perioperative cognitive behavioural therapy (CBT) vs pain education and mindfulness programme
Primary endpoint
Brief Pain Inventory (BPI) average pain severity
Follow-up
3 months
Methodological detailsparallel group
  • Parallel group

Primary result

As reported in the abstract

BPI average pain intensity score

Pain education and mindfulness (PEM)

0

median · IQR 0–1

CBT

0

median · IQR 0–1

P = 0.45

Secondary outcomes

Quality of recovery at 24 h, pain interference, pain catastrophising, anxiety, mood · 3 months

No significant between group differences

Within-group change vs preoperative baseline · 3 months

Pain interference improved (PEM / CBT)
P = 0.05 / P=0.01
Catastrophising improved (PEM / CBT)
P < 0.01 / P<0.01
Anxiety improved (PEM / CBT)
P < 0.01 / P<0.01
Mood improved (PEM / CBT)
P = 0.03 / P=0.01
  • Within group improvements in both arms

Original publication

Perioperative cognitive behavioural therapy compared with pain education and mindfulness for chronic postsurgical pain in breast cancer patients with high pain catastrophising characteristics: a randomised, controlled, parallel group clinical trial. BJA Open. Published 30 October 2025. doi:10.1016/j.bjao.2025.100499

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.